Today in Biology — Aug 12

[THEO] Alright, Mara, you know how sometimes it feels like the future of science is just… happening *to* us? Like we're just along for the ride?

[DR. MARA] I would say, Theo, that scientific progress rarely just "happens." It is often quite intentionally steered.

[THEO] Exactly! And today, we're talking about who's doing that steering, especially here in the US, and where the big pushes are coming from. Because there's a lot of money and a lot of focus right now on some pretty specific areas.

[DR. MARA] Indeed. We are seeing some significant national initiatives taking shape, particularly at the intersection of AI and scientific discovery, and how that influences funding.

[THEO] Let's dive right into the biggest splash we've seen recently: the Department of Energy's Genesis Mission. I mean, five billion dollars and 278 projects selected in one go? That's… that's a *lot* of science.

[DR. MARA] It is an unprecedented scale for a single funding round from the DOE. This mission is explicitly focused on accelerating AI innovation, particularly for scientific applications. It's a clear signal that the DOE views AI as a foundational technology for future scientific breakthroughs.

[THEO] And it's not just the DOE. NIST, the National Institute of Standards and Technology, just joined the Genesis Mission too. So you've got this really broad federal effort. For people working in biology, especially engineering biology, why does this matter *now*?

[DR. MARA] It matters because these initiatives are creating infrastructure and foundational models. If you're developing new molecular tools, or trying to engineer a non-model organism, the Genesis Mission is working to provide the AI systems that could, for example, predict protein structures for novel enzymes, or optimize metabolic pathways with far greater efficiency than traditional methods. It's about building the computational muscle for biological engineering. The goal is to move beyond general-purpose AI and towards models specifically trained on scientific datasets.

[THEO] So, instead of a general AI that can write a poem *and* code, they want an AI that's like, a biochemist and a geneticist rolled into one?

[DR. MARA] Precisely. An AI that understands the nuances of chemical reactions, genetic interactions, and biological systems at a fundamental level. This requires immense, specialized datasets and targeted model development.

[THEO] Meanwhile, on the funding front, the NIH is still playing catch-up a bit, though they're spending faster. They've got almost $11 billion left to spend by the end of the fiscal year. That's a lot of grant money waiting to find a home.

[DR. MARA] Yes, the NIH is pacing to spend its budget by September 30th. While this is typical at the end of a fiscal year, it underscores the constant flow of federal support into biomedical research. For engineering biology, this means continued opportunities, particularly in areas relevant to human health.

[THEO] And then there's ARPA-H, which feels like it’s picking up steam. We're seeing them invest in some really specific, high-impact areas. Like this $26 million for a DNA manufacturing project, focused on scalable cell-free DNA production.

[DR. MARA] ARPA-H's model is to fund high-risk, high-reward projects with potential for transformative impact. The cell-free DNA manufacturing project is a good example. Scalable, efficient DNA synthesis is a bottleneck for many applications in synthetic biology, including gene therapy vectors, vaccine development, and even basic research into novel genetic circuits. Improving this capability directly accelerates the pace of engineering biology.

[THEO] So, if you're trying to build new genetic systems, getting the DNA you need is often the slow part, and this could really speed that up, like building blocks just appear faster?

[DR. MARA] Effectively, yes. It's about streamlining the foundational steps of biological design and construction. They're also investing in better fetal monitoring technology, which again, is about developing novel tools to get clearer pictures of complex biological systems.

[THEO] Now, shifting gears a bit to what people are buzzing about online. There’s a discussion around the Amazon rainforest and whether it's closer to a tipping point than we thought. That's a big environmental concern.

[DR. MARA] It is. Changes in global ecosystems have direct implications for biodiversity and the potential for discovering new biological systems and molecules, which are often the feedstock for engineering biology. The stability of these environments is critical.

[THEO] And then, over on the social platforms, there's a lot of talk from the Department of Energy about building big things in the US, expanding American energy, and strengthening critical mineral supply chains. "Mine, baby, mine!" was the phrase that caught my eye.

[DR. MARA] Those discussions, while focused on infrastructure and natural resources, indirectly connect to biology through the drive for sustainable practices and potentially new biotechnologies for mineral extraction or remediation. The focus on domestic supply chains also highlights national priorities that can influence research funding and strategic investments in related scientific fields.

[THEO] So, we've got this huge push in AI for science, especially from the DOE, a steady flow of NIH funding, and ARPA-H making targeted, high-impact bets on foundational tech like DNA manufacturing. It really feels like the steering wheel is firmly in the hands of those pushing for AI-driven, engineering-focused biological innovation.

[DR. MARA] That's a fair assessment. The emphasis is clearly on accelerating the cycle of design, build, test, and learn in biology, leveraging advanced computational tools to do so. It reflects a strategic national interest in maintaining leadership in these rapidly evolving fields.

[THEO] Fascinating. Alright, when we come back, we're diving into...